Minerva Neurosciences, Inc. Investing Cash Flow
Minerva Neurosciences, Inc. (NERV) reported Investing Cash Flow of -$50.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-07
- Minerva Neurosciences, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$4.83M.
- Minerva Neurosciences, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$45.29M.
- Minerva Neurosciences, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00.
- Minerva Neurosciences, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
- Minerva Neurosciences, Inc. net cash provided by (used in) investing activities for fiscal 2025 was $0.00.
- Minerva Neurosciences, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $0.00.
- Minerva Neurosciences, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $0.00.
- Minerva Neurosciences, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$16.33K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$50.13M 10-Q · filed 2026-08-07 | -$50.13M derived: sum of 3 quarters · filed 2026-08-07 | -$50.13M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$45.29M 10-Q · filed 2026-05-05 | -$45.29M derived: sum of 2 quarters · filed 2026-05-05 | -$45.29M derived: sum of 3 quarters · filed 2026-05-05 | -$45.29M derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | $0.00 derived: sum of 3 quarters · filed 2026-03-11 | $0.00 10-K · filed 2026-03-11 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-05 | $0.00 derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-05-05 | $0.00 derived: sum of 3 quarters · filed 2026-05-05 | $0.00 derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | $0.00 derived: sum of 3 quarters · filed 2026-03-11 | $0.00 10-K · filed 2026-03-11 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2025-08-14 | $0.00 derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2025-05-13 | $0.00 derived: sum of 3 quarters · filed 2025-05-13 | $0.00 derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 | -$16.33K derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | -$16.33K derived: sum of 3 quarters · filed 2024-08-06 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-01 | -$16.33K derived: sum of 2 quarters · filed 2024-05-01 | ||
| 2022-12-31 | -$16.33K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$16.33K 10-K · filed 2024-02-22 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.00M derived: sum of 2 quarters · filed 2022-03-01 | $7.50M derived: sum of 3 quarters · filed 2022-03-01 | $24.53M 10-K · filed 2022-03-01 |
| 2020-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $7.50M derived: sum of 2 quarters · filed 2021-11-08 | $24.53M 10-Q · filed 2021-11-08 | $22.22M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $21.53M 10-Q · filed 2021-08-02 | $19.22M derived: sum of 3 quarters · filed 2021-08-02 | $38.80M derived: sum of 4 quarters · filed 2021-08-02 |
| 2020-03-31 | $17.03M 10-Q · filed 2021-05-12 | $14.72M derived: sum of 2 quarters · filed 2021-05-12 | $34.30M derived: sum of 3 quarters · filed 2021-05-12 | $41.66M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $17.27M derived: sum of 2 quarters · filed 2021-03-08 | $24.64M derived: sum of 3 quarters · filed 2021-03-08 | $14.08M 10-K · filed 2021-03-08 |
| 2019-09-30 | $19.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $26.95M derived: sum of 2 quarters · filed 2020-11-02 | $16.40M 10-Q · filed 2020-11-02 | -$11.03M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | $7.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | -$3.18M 10-Q · filed 2020-08-03 | -$30.61M derived: sum of 3 quarters · filed 2020-08-03 | -$1.11M derived: sum of 4 quarters · filed 2020-08-03 |
| 2019-03-31 | -$10.55M 10-Q · filed 2020-05-04 | -$37.98M derived: sum of 2 quarters · filed 2020-05-04 | -$8.48M derived: sum of 3 quarters · filed 2020-05-04 | $27.62M derived: sum of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | -$27.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $2.07M derived: sum of 2 quarters · filed 2020-03-09 | $38.17M derived: sum of 3 quarters · filed 2020-03-09 | $69.49M 10-K · filed 2020-03-09 |
| 2018-09-30 | $29.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $65.60M derived: sum of 2 quarters · filed 2019-11-04 | $96.92M 10-Q · filed 2019-11-04 | $96.89M derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $36.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $67.42M 10-Q · filed 2019-08-05 | $67.39M derived: sum of 3 quarters · filed 2019-08-05 | -$12.41M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | $31.32M 10-Q · filed 2019-05-06 | $31.29M derived: sum of 2 quarters · filed 2019-05-06 | -$48.51M derived: sum of 3 quarters · filed 2019-05-06 | |
| 2017-12-31 | -$23.87K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$79.82M derived: sum of 2 quarters · filed 2019-03-12 | -$107.19M 10-K · filed 2019-03-12 | |
| 2017-09-30 | -$79.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$107.16M 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | -$27.37M 10-Q · filed 2018-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |